Back
Pharvaris NV Vs. ProQR Therapeutics NV Industry Stock Comparison
Buy
59
PHVS
Pharvaris NV
Last Price:
22.09
Seasonality Move:
103.13%
Buy
51
PRQR
ProQR Therapeutics NV
Last Price:
3.63
Seasonality Move:
8.38%
Buy
59
Pharvaris NV (PHVS)
is a Buy
Is Pharvaris NV a Buy, Sell or Hold?
- The current Pharvaris NV [PHVS] share price is $22.29. The Score for PHVS is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- PHVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
ProQR Therapeutics NV (PRQR)
is a Buy
Is ProQR Therapeutics NV a Buy, Sell or Hold?
- The current ProQR Therapeutics NV [PRQR] share price is $3.62. The Score for PRQR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- PRQR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PHVS Stock Price Chart
What is Pharvaris NV's stock price today?
-
The Pharvaris NV share price today is $22.29
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $3.62
The current trend is moderately bullish and PRQR is experiencing slight selling pressure.
PHVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 54.95 | Buy |
| Chaikin Money Flow: | 146666 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.69 - 23.79) | Buy |
| Bollinger Bands (100): | (17.22 - 21.54) | Buy |
PRQR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 54.6 | Buy |
| Chaikin Money Flow: | -35463 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.49 - 3.87) | Sell |
| Bollinger Bands (100): | (1.55 - 3.21) | Buy |
PHVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.79 | Buy |
| 20-day SMA: | 22.28 | Buy |
| 50-day SMA: | 20.79 | Buy |
| 200-day SMA: | 20.7 | Buy |
| 8-day EMA: | 21.24 | Buy |
| 20-day EMA: | 21.46 | Buy |
| 50-day EMA: | 20.91 | Buy |
| 200-day EMA: | 20.16 | Buy |
PRQR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.74 | Sell |
| 20-day SMA: | 3.68 | Sell |
| 50-day SMA: | 2.84 | Buy |
| 200-day SMA: | 2.19 | Buy |
| 8-day EMA: | 3.69 | Sell |
| 20-day EMA: | 3.58 | Buy |
| 50-day EMA: | 3.08 | Buy |
| 200-day EMA: | 2.33 | Buy |
Pharvaris NV Earnings Growth & PHVS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.35 per share.
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.06 per share.
Pharvaris NV Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProQR Therapeutics NV Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||